Recombinant DNA Product
Showing 1 - 25 of >10,000
COVID-19 Trial in Rockville (Ad26 COVID-19 Spike plus TICE® BCG Mix for Intradermal Injection)
Active, not recruiting
- COVID-19
- Recombinant COVID-19 Spike Protein plus TICE® BCG Mix for percutaneous use
-
Rockville, Maryland
- +1 more
Jan 18, 2023
cfDNA Test for Non-invasive Cytogenetic Analysis of Early
Not yet recruiting
- Spontaneous Miscarriage
- Curettage for the evacuation of the product of conception
-
Bron, Rhône, France
- +1 more
Jun 14, 2023
SARS-CoV-2 Trial in New York (Sodium Chloride, NDV-HXP-S IN low dose, NDV-HXP-S IM low dose)
Recruiting
- SARS-CoV-2
- Sodium Chloride
- +4 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 30, 2022
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)
Active, not recruiting
- HIV Infections
- env (A,B,C,A/E)/gag (C) DNA Vaccine
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 8, 2022
Nasopharyngeal Cancer, Epstein-Barr Virus Infections Trial in Hong Kong (Recombinant Epstein-Barr Virus (EBV) Vaccine)
Completed
- Nasopharyngeal Cancer
- Epstein-Barr Virus Infections
- Recombinant Epstein-Barr Virus (EBV) Vaccine
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital
Jul 26, 2021
HIV Trial in United States (DNA plasmid vaccine, Recombinant adenoviral serotype 5 (rAD5) vector vaccine, DNA vaccine )
Terminated
- HIV Infections
- DNA plasmid vaccine
- +3 more
-
Birmingham, Alabama
- +21 more
Oct 13, 2021
Healthy Volunteers Trial in Neuss (Biocon's Human Insulin R U-500, Humulin® R U-500 (US Reference Product))
Recruiting
- Healthy Volunteers
- Biocon's Human Insulin R U-500
- Humulin® R U-500 (US Reference Product)
-
Neuss, GermanyProfil Institut für Stoffwechselforschung GmbH 9
Jun 9, 2022
HIV Trial in United States (Clade B gag DNA/PLG and env DNA/PLG Microparticles, Clade B Recombinant, Oligomeric gp140/MF59
Completed
- HIV Infections
- Clade B gag DNA/PLG and env DNA/PLG Microparticles
- Clade B Recombinant, Oligomeric gp140/MF59 Adjuvant
-
Saint Louis, Missouri
- +3 more
Oct 13, 2021
HIV Trial in United States (DNA Vaccine, DNA Vaccine , rAd35)
Completed
- HIV Infections
- DNA Vaccine
- +5 more
-
Birmingham, Alabama
- +9 more
Oct 13, 2021
Sleep Restriction Trial in Torrance (Ketoconazole Pill (also known as nizoral), Ganirelix, Dexamethasone Pill)
Active, not recruiting
- Sleep Restriction
- Ketoconazole Pill (also known as nizoral)
- +11 more
-
Torrance, CaliforniaLos Angeles Biomedical Research Institute
Oct 25, 2022
Sleep Restriction Trial in Torrance (Ketoconazole Pill, Ganirelix, Dexamethasone)
Active, not recruiting
- Sleep Restriction
- Ketoconazole Pill
- +11 more
-
Torrance, CaliforniaLos Angeles Biomedical Research Institute
Mar 11, 2022
HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )
Withdrawn
- HIV Infections
- VRC-HIVDNA016-00-VP
- +3 more
- (no location specified)
Oct 28, 2021
Cancer, Solid Tumor Trial in Houston (drug, biological, diagnostic test)
Completed
- Cancer
- Solid Tumor
- Fludarabine
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 14, 2022
Hepatitis B Trial in Bandung (Recombinant Hepatitis B (Bio Farma) Vaccine, Recombinant Hepatitis B (Bio Farma) Vaccine®)
Completed
- Hepatitis B
- Recombinant Hepatitis B (Bio Farma) Vaccine
- Recombinant Hepatitis B (Bio Farma) Vaccine®
-
Bandung, West Java, IndonesiaHasan Sadikin Hospital
Jul 29, 2022
Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- bevacizumab
- +5 more
-
Los Angeles, California
- +2 more
Feb 10, 2022
HIV Trial in Kampala (VRC-HIVADV014-00-VP Vaccine)
Completed
- HIV Infections
- VRC-HIVADV014-00-VP Vaccine
-
Kampala, UgandaMakerere University Walter Reed Project (MUWRP)
Oct 28, 2021
Subjects Previously Enrolled in NCI Genitourinary Malignancies
Enrolling by invitation
- Cervical Intraepithelial Neoplasia
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Chronic Kidney Disease (CKD) Trial in Jakarta
Completed
- Chronic Kidney Disease (CKD)
-
Jakarta, DKI Jakarta, IndonesiaGatot Soebroto Army Hospital
Jul 19, 2022
Hemophilia A Trial in Tianjin (Single dose intravenous injection of BBM-H803)
Recruiting
- Hemophilia A
- Single dose intravenous injection of BBM-H803
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital Chinese Academ
Oct 31, 2023
HIV Trial in Boston, Seattle (HIV-1 DNA plasmid vaccine, HIV-1 recombinant Ad5 vaccine)
Completed
- HIV Infections
- HIV-1 DNA plasmid vaccine
- HIV-1 recombinant Ad5 vaccine
-
Boston, Massachusetts
- +1 more
Oct 13, 2021
Prostate Cancer Trial in New Brunswick, Seattle, Madison (pTVG-AR, gm-csf)
Completed
- Prostate Cancer
- pTVG-AR
- gm-csf
-
New Brunswick, New Jersey
- +2 more
Feb 2, 2021